CARDIOVASCULAR IMAGING IN CORONARY HEART DISEASE IN WOMEN ORGANIZM
Keywords:
Cardiovascular diseases; heart disease in women; visualization; ischemia.Abstract
Heart disease is the leading cause of death among men and women. Women have a unique coronary heart disease phenotype with fewer calcified lesions, more non-obstructive plaque, and a higher prevalence of microvascular disease compared with men, which may partly explain why current risk models for identifying obstructive coronary artery disease (CAD) may fail. so do women. This article summarizes sex differences in the functional and anatomical assessment of CAD in women with stable chest pain and proposes an approach to using multimodality imaging to evaluate suspected CAD in women according to recently published American Heart Association/American Heart Association data. College of Cardiology guidelines for the assessment and diagnosis of chest pain. A paradigm shift in the approach to imaging women with coronary artery disease is needed, including updated risk models, a better understanding of CAD in women in whom nonobstructive disease is more common, and algorithms focused on the assessment of ischemia in nonobstructive CAD and myocardial infarction in nonobstructive CAD.
References
S.S. Virani, A. Alonso, E.J. Benjamin, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association Circulation, 141 (9) (2020), pp. E139-e596
N.R. Aggarwal, H.N. Patel, L.S. Mehta, et al. Sex differences in ischemic heart disease: advances, obstacles, and next steps
M.R. Patel, D. Dai, A.F. Hernandez, et al. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practiceAm Heart J, 167 (6) (2014), pp. 846-852.e2
R.J. Dolor, M.R. Patel, C. Melloni, et al. Noninvasive technologies for the diagnosis of coronary artery disease in women AHRQ Comparative Effectiveness Reviews, Agency for Healthcare Research and Quality (US) (2012)
Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, Flather M, et al. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018;379:924–933. doi: 10.1056/NEJMoa1805971.
Tunc E, Eve AA, Madak-Erdogan Z. Coronary microvascular dysfunction and estrogen receptor signaling. Trends Endocrinol Metab. 2020;31:228–238. doi: 10.1016/j.tem.2019.11.001.
Haider A, Bengs S, Luu J, Osto E, Siller-Matula JM, Muka T, et al. Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J. 2020;41:1328–1336. doi: 10.1093/eurheartj/ehz898.
Ketelhuth DFJ, Lutgens E, Bäck M, Binder CJ, Van den Bossche J, Daniel C, et al. Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology. Cardiovasc Res. 2019;115:1385–1392. doi: 10.1093/cvr/cvz166. [